SavedAdd your journal

Journals / Ulusal Cerrahi Dergisi / 2013 / Cilt: 29 - Sayı: 2

Restaging colorectal cancer and PET/CT

Kolorektal kanser yeniden evrelemesi ve PET/BT

Alev ÇINAR
Esra Arzu GENÇOĞLU
MELİHA KORKMAZ
Pages
76–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Its ability to detect the metabolic/functional changes in patients with colorectal cancer during the early stages, in which no morphological changes occur, is significantly better than the other imaging modalities.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Positron Emission Tomography/Computerized Tomography (PET/CT), is an important assessment method in restaging oncology patients.
📊
Key Findings & Data:Positron Emission Tomography/Computerized Tomography (PET/CT), is an important assessment method in restaging oncology patients.
💡
Conclusion & Impact:Its ability to detect the metabolic/functional changes in patients with colorectal cancer during the early stages, in which no morphological changes occur, is significantly better than the other imaging modalities.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Positron Emission Tomography/Computerized Tomography (PET/CT), is an important assessment method in restaging oncology patients. Its ability to detect the metabolic/functional changes in patients with colorectal cancer during the early stages, in which no morphological changes occur, is significantly better than the other imaging modalities.

Özet

Pozitron Emisyon Tomografi/Bilgisayarlı Tomografi (PET/BT), günümüzde onkolojik hasta grubunun yeniden evrele- mesinde ön plana çıkmış görüntüleme yöntemidir. Kolorektal kanserlerde morfolojik değişikliklerin henüz oluşma- dığı erken dönemlerde tümöral dokuda var olan metabolik/fonksiyonel değişikliği gösterebilmesi PET/BT’nin diğer radyolojik yöntemlere olan üstünlüğüdür.

🔖

Cite This Article

ÇINAR, A., GENÇOĞLU, E. A., KORKMAZ, M. (2013). Restaging colorectal cancer and PET/CT. Ulusal Cerrahi Dergisi, Cilt: 29 - Sayı: 2, 76–80. https://ajindex.com/articles/325756

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Kalaycı G. Kolon Kanserleri, Genel Cerrahi, Nobel Tıp Kitabevi İs- tanbul 2002: 1343-1359. 2.Topuz E, Aykan FN. Sindirim Sistemi Kanserleri. İstanbul Üniversi- tesi Onkoloji Enstitü Yayınları 1998: 373-475. 3. Fenoglio-Preiser CM, Noffsinger AE. Other Tumours of the Large İntestine, In: Gastrointestinal and Oesophageal Pathology, ed. Whitehead R, Churchill Livingstone, New York 2nd ed., 1995: 863-905. 4. Rosai J. Large Bowel. In: Ackerman’s Surgical Pathology, ed. Rosai J. St Louis, 8th ed., Mosby, 1996: 729-799. 5. Winawer SJ, Zauber AG, Gerdes H, O’Brien MJ, Gottlieb LS, Sternberg SS, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996
  2. [CrossRef] 6. Cusack JC, Giacco GG, Cleary K, Davidson BS, Izzo F, Skibber J, et al. Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg 1996
  3. Messerini L, Palomba A, Zampi G. Primary signet-ring cell carcinoma of the colon and rectum. Dis Colon Rectum 1995
  4. [CrossRef] 8. de Bruïne AP, Wiggers T, Beek C, Volovics A, von Meyenfeldt M, Arends JW, et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer 1993
  5. [CrossRef] 9. Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, et al. Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study. Int J Colorectal Dis 2011
  6. [CrossRef] 10. Greene F, Stewart A, Norton H. A new TNM staging strategy for node-positive (stage III) colon cancer: an analysis of 50,042 patients. Ann Surg 2002
  7. [CrossRef] 11. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999
  8. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of fluor-18-dexyglucose-positron emission tomography in the management of colorectal liver metastases: A systematic review and metaanalysis. Cancer 2005
  9. [CrossRef] 13. Potter KC, Husband JE, Houghton SL, Thomas K, Brown G. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence. Dis Colon Rectum 2009
  10. [CrossRef] 14. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cance